Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, May 1, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Pharma
Kite’s Tecartus® Demonstrates High Response Rate in Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Life Sciences Times
-
June 4, 2021
0
People on the Move
Janux Therapeutics Appoints Dr. Wayne Godfrey as Chief Medical Officer
Life Sciences Times
-
June 3, 2021
0
Venture Capital
venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences
Life Sciences Times
-
June 3, 2021
0
Venture Capital
Bayer Acquires Noria and PSMA Therapeutics to Expand Pipeline in Prostate Cancer
Life Sciences Times
-
June 3, 2021
0
Venture Capital
Blackstone Has Acquired Desotec
Life Sciences Times
-
June 3, 2021
0
Life Sciences
Harvard Licenses Technology to Obatala Sciences to Advance Discovery in Obesity, Diabetes, and Cancer
Life Sciences Times
-
June 2, 2021
0
Pharma
Cytovale Begins Enrollment in FDA 510(k) Clinical Validation Study of IntelliSep Rapid Sepsis Test
Life Sciences Times
-
June 2, 2021
0
Venture Capital
Nayya Raises $37 Million in Series B Growth Capital, co-led by SVB Capital and ICONIQ Growth
Life Sciences Times
-
June 2, 2021
0
Venture Capital
Oxford Finance Provides $24 Million Credit Facility to Lantern Group
Life Sciences Times
-
June 2, 2021
0
People on the Move
Inspira Health Appoints Warren E. Moore, FACHE as the New Executive Vice President, Chief Operating Officer
Life Sciences Times
-
June 2, 2021
0
1
...
779
780
781
...
831
Page 780 of 831
Most Popular
Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board
May 1, 2026
SK Capital Completes Sale of Noramco Group Businesses to Siegfried
May 1, 2026
GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients
May 1, 2026
Seaport Therapeutics Prices Upsized IPO at $18 Per Share
May 1, 2026
Load more
Recent Comments
Recent Comments